American Heart Journal

1. Am Heart J28 Feb 2026

   Rationale, design, and baseline characteristicss of the effect of PCSK9 inhibition on cardiovascular risk in treated HIV infection: EPIC-HIV randomized clinical trial

   Trial designPrevention & lipids

2. Am Heart J25 Feb 2026

   Operator radiation exposure comparing left-radial artery and right-radial artery approaches: A systematic review and meta-analysis

   Meta-analysisCoronary & ACS

3. Am Heart J24 Feb 2026

   Remote dietitian counseling with short-term meal delivery improves DASH diet adherence and lowers blood pressure in veterans with hypertension and obesity

   Randomised controlled trialHypertension

4. Am Heart J23 Feb 2026

   Design and rationale of the COMPARE-TAVI 2 trial: An all-comers head-to-head comparison of Evolut FX+ and Sapien 3 Ultra Resilia transcatheter heart valves

   Trial designValvular & structural

5. Am Heart J19 Feb 2026

   Effect of age on restrictive and liberal transfusion outcomes in patients with anemia and myocardial infarction

   Secondary analysisCoronary & ACS

6. Am Heart J18 Feb 2026

   Design and rationale of RECOVER-AUTONOMIC: A randomized platform trial evaluating interventions for Long COVID postural orthostatic tachycardia syndrome

   Trial designCardio-oncology & other

7. Am Heart J18 Feb 2026

   A comprehensive set of per-protocol analyses of the myocardial ischemia and transfusion (MINT) trial

   Research articleCoronary & ACS

8. Am Heart J17 Feb 2026

   Integration of a task strengthening strategy for hypertension management into HIV care in Nigeria: Baseline characteristics of participants in a cluster randomized controlled trial

   Randomised controlled trialHypertension

9. Am Heart J11 Feb 2026

   Exercise treadmill testing for efficacy evaluation in randomized, controlled trials

   Randomised controlled trialCoronary & ACS

10. Am Heart J10 Feb 2026

    Design and rationale of a multicenter paramedic randomized trial of noradrenaline versus adrenaline in the initial management of patients with cardiogenic shock—The PANDA trial

    Trial designAcute care & resuscitation

11. Am Heart J10 Feb 2026

    Rationale and design of a pragmatic randomized clinical trial assessing a smartphone-based digital health intervention in hypertension: The ELFIE-HYPERTENSION trial

    Trial designHypertension

12. Am Heart J5 Feb 2026

    Probabilities of treatment effects in complete or culprit-only revascularization for NSTEMI: A Bayesian re-analysis of the SLIM trial

    Secondary analysisCoronary & ACS

13. Am Heart J3 Feb 2026

    Reperfusion strategies for acute pulmonary embolism: Design and rationale of RECONNECT-PE—A living systematic review and meta-analysis

    Trial designPulmonary vascular & VTE

14. Am Heart J3 Feb 2026

    Association between atherosclerosis and atrial fibrillation progression in patients with paroxysmal atrial fibrillation: Data from the RACE V study

    Secondary analysisArrhythmias & EP

15. Am Heart J2 Feb 2026

    Study design for an emulated trial of a 2 arm, parallel, stratified, adaptive, RCT of CABG versus PCI in people requiring myocardial revascularization at high risk (High-Risk REVASC)

    Trial designCoronary & ACS

16. Am Heart J2 Feb 2026

    Left Atrial Appendage Occlusion Versus NOACs in patients With Atrial Fibrillation: Rationale and Design of the CATALYST Trial

    Trial designArrhythmias & EP

17. Am Heart J29 Jan 2026

    Primary percutaneous coronary intervention within the first hour: Insights from early-treated patients with ST-elevation myocardial infarction

    Research articleCoronary & ACS

18. Am Heart J28 Jan 2026

    STrategies for antithrombotic tRreatment following transcatheter edge-to-edge repair in patients with severe mitral regurgitation: Rationale and design of STAR-TEER trial

    Trial designValvular & structural

19. Am Heart J27 Jan 2026

    Low levels of atherogenic lipoproteins and incident atherosclerotic cardiovascular disease: A pooled cohort primary prevention study

    Cohort studyPrevention & lipids

20. Am Heart J27 Jan 2026

    Safety of a remote disease management program to improve sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists prescribing in type 2 diabetes with elevated cardiovascular or kidney risk

    Randomised controlled trialCardiometabolic & kidney

21. Am Heart J26 Jan 2026

    Evidence supporting the role of longitudinal NT-proBNP assessment for risk stratification in adults with congenital heart disease

    Cohort studyCongenital

22. Am Heart J26 Jan 2026

    Admission rates for pediatric supraventricular tachycardia are affected by primary insurance payor: An analysis of the NEDS database

    Cohort studyArrhythmias & EP

23. Am Heart J25 Jan 2026

    Study evaluating dexmedetomidine in the acute treatment of electrical storm (SEDATE): Rationale and design

    Trial designArrhythmias & EP

24. Am Heart J22 Jan 2026

    Integrated care management for older multimorbid patients with atrial fibrillation: Rationale, design and baseline characteristics for the atrial fibrillation integrated approach in frail, multimorbid and polymedicated older people (AFFIRMO) trial

    Trial designArrhythmias & EP

25. Am Heart J19 Jan 2026

    Early outcomes of off-label transcatheter tricuspid valve repair/replacement in the STS/ACC TVT registry

    Cohort studyValvular & structural

26. Am Heart J13 Jan 2026

    Staged interventional strategies for acute ST-segment elevation myocardial infarction patient with multivessel disease: Rationale and design of a multicenter, randomized STAGED trial

    Trial designCoronary & ACS

27. Am Heart J6 Jan 2026

    Reproductive health outcomes of congenital heart disease survivors: A report from the congenital heart disease project to understand lifelong survivor experience (CHD PULSE study)

    Cross-sectional studyCongenital

28. Am Heart J6 Jan 2026

    Design and rationale of the GUARD-OAC: A randomized controlled trial evaluating proton pump inhibitor cotherapy for gastrointestinal protection in patients requiring direct oral anticoagulants

    Trial designArrhythmias & EP

29. Am Heart J3 Jan 2026

    Intravascular ultrasound guidance for complex high-risk indicated procedures: The IVUS CHIP trial study design

    Trial designCoronary & ACS

30. Am Heart J2 Jan 2026

    Design and rationale of the WARRIOR ancillary study for coronary CT angiographic analysis

    Trial designCoronary & ACS

All 150 Briefs in ExploreShowing Briefs 121–150 of 150, newest first